Increased AKT S473 phosphorylation after mTORC1 inhibition is rictor dependent and does not predict tumor cell response to PI3K/mTOR inhibition
Breuleux, Madlaina, Klopfenstein, Matthieu, Stephan, Christine, Doughty, Cheryl A, Barys, Louise, Maira, Saveur-Michel, Kwiatkowski, David, Lane, Heidi A
Published in Molecular cancer therapeutics (01.04.2009)
Published in Molecular cancer therapeutics (01.04.2009)
Get full text
Journal Article
NVP-BEZ235 as a New Therapeutic Option for Sarcomas
Manara, Maria C, Nicoletti, Giordano, Zambelli, Diana, Ventura, Selena, Guerzoni, Clara, Landuzzi, Lorena, Lollini, Pier-Luigi, Maira, Saveur-Michel, García-Echeverría, Carlos, Mercuri, Mario, Picci, Piero, Scotlandi, Katia
Published in Clinical cancer research (15.01.2010)
Published in Clinical cancer research (15.01.2010)
Get full text
Journal Article
PI3K and mTOR inhibitors — a new generation of targeted anticancer agents
Brachmann, Saskia, Fritsch, Christine, Maira, Saveur-Michel, García-Echeverría, Carlos
Published in Current opinion in cell biology (01.04.2009)
Published in Current opinion in cell biology (01.04.2009)
Get full text
Journal Article
Structure of the MRAS-SHOC2-PP1C phosphatase complex
Hauseman, Zachary J, Fodor, Michelle, Dhembi, Anxhela, Viscomi, Jessica, Egli, David, Bleu, Melusine, Katz, Stephanie, Park, Eunyoung, Jang, Dong Man, Porter, Kathryn A, Meili, Fabian, Guo, Hongqiu, Kerr, Grainne, Mollé, Sandra, Velez-Vega, Camilo, Beyer, Kim S, Galli, Giorgio G, Maira, Saveur-Michel, Stams, Travis, Clark, Kirk, Eck, Michael J, Tordella, Luca, Thoma, Claudio R, King, Daniel A
Published in Nature (London) (08.09.2022)
Published in Nature (London) (08.09.2022)
Get full text
Journal Article
Abstract 5255: NVP-BEZ235 a dual PI3K/mTOR inhibitor destabilises Mycn in vitro and is growth inhibitory in the TH-MYCN murine neuroblastoma model
Vaughan, Lynsey S., Cullis, Elizabeth, Barker, Karen, Jamin, Yann, Robinson, Simon, Maira, Saveur-Michel, Chesler, Louis
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Published in Cancer research (Chicago, Ill.) (15.04.2010)
Get full text
Journal Article
Anti-Myeloma Activity of Selective PI-3K/PDK/mTOR Inhibitor BEZ235
McMillin, Douglas W., Negri, Joseph, Delmore, Jake, Hayden, Patrick, Mitsiades, Nicholas, Richardson, Paul G., Munshi, Nikhil C., Schlossman, Robert, Maira, Saveur-Michel, García-Echeverría, Carlos, Anderson, Kenneth C., Mitsiades, Constantine S.
Published in Blood (16.11.2007)
Published in Blood (16.11.2007)
Get full text
Journal Article
Use of 2-carboxamide cycloamino urea derivatives in the treatment of EGFR dependent diseases or diseases that have acquired resistance to agents that target EGFR family members
MAIRA, Saveur-Michel, BRACHMANN, Saskia Maria, SCHNELL, Christian Renee, FRITSCH, Christine, Garcia-Echeverria, Carlos
Year of Publication 23.01.2020
Get full text
Year of Publication 23.01.2020
Patent